Early evaluation of tumor response using contrast-enhanced ultrasonography for hepatocellular carcinoma treated with Solafenib
Not Applicable
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000004599
- Lead Sponsor
- Yokohama City University Medical Center Gastroenterological Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. T-Bil >3.0g/dl, PT 50%> 2.woman before menopause 3. woman during pregnancy or breast-feeding, who has plan for pregnancy 4. patient who has massive fluid collection 5. patient whom the doctor think as inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method